Romano Brothers And Company Amgen Inc Transaction History

Romano Brothers And Company

  • $788 Million
  • Q3 2024

A detailed history of Romano Brothers And Company transactions in Amgen Inc stock. As of the latest transaction made, Romano Brothers And Company holds 20,657 shares of AMGN stock, worth $5.79 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
20,657
Previous 20,871 1.03%
Holding current value
$5.79 Million
Previous $6.52 Million 2.05%
% of portfolio
0.84%
Previous 0.91%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
SELL
$309.38 - $337.38 $66,207 - $72,199
-214 Reduced 1.03%
20,657 $6.66 Million
Q2 2024

Jul 17, 2024
SELL
$262.75 - $319.31 $83,817 - $101,859
-319 Reduced 1.51%
20,871 $6.52 Million
Q1 2024

Apr 17, 2024
SELL
$268.87 - $324.56 $26,618 - $32,131
-99 Reduced 0.47%
21,190 $6.02 Million
Q4 2023

Jan 29, 2024
BUY
$255.7 - $288.46 $5.44 Million - $6.14 Million
21,289 New
21,289 $6.13 Million
Q3 2023

Oct 17, 2023
BUY
$218.65 - $271.46 $4.79 Million - $5.95 Million
21,922 New
21,922 $5.89 Million
Q2 2023

Jul 12, 2023
SELL
$214.27 - $253.37 $104,992 - $124,151
-490 Reduced 2.19%
21,922 $4.87 Million
Q1 2023

Apr 13, 2023
SELL
$225.79 - $275.2 $22,579 - $27,520
-100 Reduced 0.44%
22,412 $5.42 Million
Q4 2022

Jan 17, 2023
BUY
$229.03 - $291.01 $76,496 - $97,197
334 Added 1.51%
22,512 $0
Q3 2022

Oct 18, 2022
BUY
$224.46 - $253.15 $4.98 Million - $5.61 Million
22,178 New
22,178 $5 Million

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Romano Brothers And Company Portfolio

Follow Romano Brothers And Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Romano Brothers And Company, based on Form 13F filings with the SEC.

News

Stay updated on Romano Brothers And Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email